A new study [33] has found that the inhibitory effect of SGLT2 inhibitors on the kidney and cardiac sodium hydrogen exchanger 3 (NHE3) may be associated with a corresponding reduction in cardiac injury, systolic dysfunction, and hypertension. The gene discussed is SLC9A3; the disease is Hypertension.